NovaBay Pharmaceuticals Selling Avenova Assets to Physician Recommended Nutraceuticals
Friday, 20 September 2024, 10:28
Strategic Sale of Avenova Assets
NovaBay Pharmaceuticals is witnessing an uptick in its share price following a major announcement. The firm has reached a definitive agreement to sell its Avenova assets to Physician Recommended Nutraceuticals for $9.5 million.
Impact on NovaBay's Financial Health
- This agreement is part of a broader strategy to strengthen NovaBay's core operations.
- The funds from this sale are expected to enhance the company's liquidity and funding for future projects.
- Both parties are optimistic about this transaction, which marks a significant shift in NovaBay's focus.
Investors should stay tuned for future developments as this sale progresses, potentially leading to an uplift in market confidence.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.